Search

everythinglearnresearchcommunity

for

Search:↓

Filler injections can cause temporary hair loss, but hyaluronidase can help restore hair within a few months.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

TrichoxidilTM could be a promising new treatment for hair loss.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Using your own skin cells can help repair aging skin and promote hair growth.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Stress can cause hair loss and skin issues by affecting hair growth cycles.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Scientists made structures that look like human hair follicles using stem cells, which could help grow hair without using actual human tissue.

The research improved understanding of yak hair growth to help use yak wool better.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Scientists found the best time to transplant human stem cells for hair growth is between days 16-18 when they have the right markers and growth potential.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Allium hookeri extract may help promote hair growth and protect cells from damage.